FDA Clearance Tracker · P840064-S089
VISCOAT Ophthalmic Viscosurgical Device
Last checked: Nov 20, 2026Latest source record: Feb 10, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 10, 2026
Approved
Time to decision
250 days
Received Jun 5, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P840064-S089
- Device name
- VISCOAT Ophthalmic Viscosurgical Device
- Applicant
- Alcon Laboratories
- Applicant location
- Fort Worth, TX
- Received
- Jun 5, 2025
- Decided
- Feb 10, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P840064
Device type
- Device type
- AID, SURGICAL, VISCOELASTIC (LZP)
- Device class
- Class III
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for adding a new fill volume (0.75 mL) of an ophthalmic viscosurgical device (OVD) into a 1 mL syringe. This would be produced at the LifeCore Biomedical site.
Source documents
Other decisions for Alcon Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.